Interpreting Plasma Estrogen Levels in Breast Cancer: Caution Needed-Reference-Cited by-同舟云学术

Interpreting Plasma Estrogen Levels in Breast Cancer: Caution Needed

Published:2014-05-10 Issue:14 Volume:32 Page:1396-1400
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Folkerd Elizabeth J.¹,Lønning Per E.²,Dowsett Mitch³

Affiliation:

1. The Institute of Cancer Research; Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom

2. University of Bergen; and Haukeland University Hospital, Bergen, Norway

3. Royal Marsden Hospital NHS Foundation Trust; Cancer Research Centre; The Institute of Cancer Research, University of London, London, United Kingdom

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2013.53.9411

Reference62 articles.

1. Standardization of Steroid Hormone Assays: Why, How, and When?

2. Deficits in plasma oestradiol measurement in studies and management of breast cancer

3. Analysis of estrogens in serum and plasma from postmenopausal women: Past present, and future

4. Aromatase and Its Inhibitors: Significance for Breast Cancer Therapy

5. Plasma estrogen suppression with aromatase inhibitors evaluated by a novel, sensitive assay for estrone sulphate

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Humanizing the endocrine milieu of female mice for women’s health-related studies;2024-09-10

2. Estrogen levels in young women with hormone receptor-positive breast cancer on ovarian function suppression therapy;npj Breast Cancer;2024-08-01

3. Measuring serum oestrogen levels in breast cancer survivors using vaginal oestrogens: a systematic review;Breast Cancer Research and Treatment;2024-05-23

4. Clinically Relevant Laboratory Monitoring of Gender-Affirming Hormone Therapy in Transgender People—Experiences from a Teaching Hospital in the Netherlands;The Journal of Applied Laboratory Medicine;2024-03-07

5. Selection of appropriate biomarkers to monitor effectiveness of ovarian function suppression in pre-menopausal patients with ER+ breast cancer;npj Breast Cancer;2024-01-19